An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International

No abstract

Bibliographic Details
Main Authors: Roman-Ulrich Müller, A. Lianne Messchendorp, Henrik Birn, Giovambattista Capasso, Emilie Cornec-Le Gall, Olivier Devuyst, Albertien van Eerde, Patrick Guirchoun, Tess Harris, Ewout J. Hoorn, Nine V.A.M. Knoers, Uwe Korst, Djalila Mekahli, Yannick Le Meur, Tom Nijenhuis, Albert C.M. Ong, John A. Sayer, Franz Schaefer, Aude Servais, Vladimir Tesar, Roser Torra, Stephen B. Walsh and Ron T. Gansevoort
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2022-02-01
Series:Počki
Online Access:https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/357
_version_ 1818551781265768448
author Roman-Ulrich Müller
A. Lianne Messchendorp
Henrik Birn
Giovambattista Capasso
Emilie Cornec-Le Gall
Olivier Devuyst
Albertien van Eerde
Patrick Guirchoun
Tess Harris
Ewout J. Hoorn
Nine V.A.M. Knoers
Uwe Korst
Djalila Mekahli
Yannick Le Meur
Tom Nijenhuis
Albert C.M. Ong
John A. Sayer
Franz Schaefer
Aude Servais
Vladimir Tesar
Roser Torra
Stephen B. Walsh and Ron T. Gansevoort
author_facet Roman-Ulrich Müller
A. Lianne Messchendorp
Henrik Birn
Giovambattista Capasso
Emilie Cornec-Le Gall
Olivier Devuyst
Albertien van Eerde
Patrick Guirchoun
Tess Harris
Ewout J. Hoorn
Nine V.A.M. Knoers
Uwe Korst
Djalila Mekahli
Yannick Le Meur
Tom Nijenhuis
Albert C.M. Ong
John A. Sayer
Franz Schaefer
Aude Servais
Vladimir Tesar
Roser Torra
Stephen B. Walsh and Ron T. Gansevoort
author_sort Roman-Ulrich Müller
collection DOAJ
description No abstract
first_indexed 2024-12-12T09:04:28Z
format Article
id doaj.art-3f3763f45a78472d9048eb2d6d9503c1
institution Directory Open Access Journal
issn 2307-1257
2307-1265
language English
last_indexed 2024-12-12T09:04:28Z
publishDate 2022-02-01
publisher Zaslavsky O.Yu.
record_format Article
series Počki
spelling doaj.art-3f3763f45a78472d9048eb2d6d9503c12022-12-22T00:29:43ZengZaslavsky O.Yu.Počki2307-12572307-12652022-02-01111373910.22141/2307-1257.11.1.2022.357357An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalRoman-Ulrich MüllerA. Lianne MesschendorpHenrik BirnGiovambattista CapassoEmilie Cornec-Le GallOlivier DevuystAlbertien van EerdePatrick GuirchounTess HarrisEwout J. HoornNine V.A.M. KnoersUwe KorstDjalila MekahliYannick Le MeurTom NijenhuisAlbert C.M. OngJohn A. SayerFranz SchaeferAude ServaisVladimir TesarRoser TorraStephen B. Walsh and Ron T. GansevoortNo abstracthttps://kidneys.zaslavsky.com.ua/index.php/journal/article/view/357
spellingShingle Roman-Ulrich Müller
A. Lianne Messchendorp
Henrik Birn
Giovambattista Capasso
Emilie Cornec-Le Gall
Olivier Devuyst
Albertien van Eerde
Patrick Guirchoun
Tess Harris
Ewout J. Hoorn
Nine V.A.M. Knoers
Uwe Korst
Djalila Mekahli
Yannick Le Meur
Tom Nijenhuis
Albert C.M. Ong
John A. Sayer
Franz Schaefer
Aude Servais
Vladimir Tesar
Roser Torra
Stephen B. Walsh and Ron T. Gansevoort
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
Počki
title An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
title_full An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
title_fullStr An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
title_full_unstemmed An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
title_short An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International
title_sort update on the use of tolvaptan for autosomal dominant polycystic kidney disease consensus statement on behalf of the era working group on inherited kidney disorders the european rare kidney disease reference network and polycystic kidney disease international
url https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/357
work_keys_str_mv AT romanulrichmuller anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT aliannemesschendorp anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT henrikbirn anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT giovambattistacapasso anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT emiliecorneclegall anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT olivierdevuyst anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT albertienvaneerde anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT patrickguirchoun anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT tessharris anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT ewoutjhoorn anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT ninevamknoers anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT uwekorst anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT djalilamekahli anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT yannicklemeur anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT tomnijenhuis anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT albertcmong anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT johnasayer anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT franzschaefer anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT audeservais anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT vladimirtesar anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT rosertorra anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT stephenbwalshandrontgansevoort anupdateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT romanulrichmuller updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT aliannemesschendorp updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT henrikbirn updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT giovambattistacapasso updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT emiliecorneclegall updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT olivierdevuyst updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT albertienvaneerde updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT patrickguirchoun updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT tessharris updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT ewoutjhoorn updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT ninevamknoers updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT uwekorst updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT djalilamekahli updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT yannicklemeur updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT tomnijenhuis updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT albertcmong updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT johnasayer updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT franzschaefer updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT audeservais updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT vladimirtesar updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT rosertorra updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational
AT stephenbwalshandrontgansevoort updateontheuseoftolvaptanforautosomaldominantpolycystickidneydiseaseconsensusstatementonbehalfoftheeraworkinggrouponinheritedkidneydisorderstheeuropeanrarekidneydiseasereferencenetworkandpolycystickidneydiseaseinternational